Vontobel Holding’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,000
Closed -$60K 1000
2020
Q4
$60K Buy
+1,000
New +$61.5K ﹤0.01% 950

Other funds holding BMY

Vontobel Holding's BMY Position: Q1 2026 in Review

Vontobel Holding reduced its Bristol-Myers Squibb (BMY) stake by 8.8% in Q1 2026, selling an estimated $3.92M and leaving 695,820 shares worth $42.2M. The position accounts for 0.15% of the portfolio, ranked #136.

Vontobel Holding first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $132M in Q4 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Vontobel Holding held 695,820 shares of Bristol-Myers Squibb worth $42.2M as of Q1 2026.
  • Vontobel Holding sold 67,308 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.92M.
  • Bristol-Myers Squibb made up 0.15% of Vontobel Holding's portfolio in Q1 2026, its #136 holding.
  • Vontobel Holding first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Bristol-Myers Squibb position peaked at $132M in Q4 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.